
In this episode, Scott Becker humorously compares his fitness journey to the performance of Amazon and Apple.
Loading summary
A
This is Scott Becker with the Becker Business and the Becker Private Equity Podcast. Today's discussion is Amazon, Apple and My Physical Fitness. So here's what these three have in common. The Magnificent Seven this year and the Nasdaq this year are overall having a terrific, terrific year. In contrast, Apple is up about 5% and Amazon's up about 2%. 2%. So there are a couple different things that all these things have in common with my own physical fitness. One, like Apple and Amazon, I am not having a great fitness year. I'm having an okay year. My weight's up about 2%. I really wanted it down about 2%. So that is the similarity to Amazon. We're both up about 2% this year. The flip side is, compared to everybody else, when I look at everybody else out there, so many people on these GLP1s, this Ozempic, the Novo Nordisk pill, or Shot, the Wegovy, and they seem to be all doing great. So their fitness is surging like the rest of the Magnificent Seven. But mine is barely budging in the right direction, if not the wrong direction again, up about 2% this year. Just like Amazon, which is up 2% this year so far, year to date, Apple's up about 5%. So thank God I'm up not, not up 5%. But compared to the rest of the of the Magnificent Seven, even Tesla's up 10 12% now. Google's up 33%. Meta Platforms is up 25%, Microsoft's up 24% or so. The whole Magnificent Seven, like the whole world that's on the GLP1s, seems to be doing great. And I, like Apple and Amazon, are just doing okay. It is what it is. This is today's discussion about Apple, Amazon and my physical fitness. Thank you for listening to the Becker Business and the Becker Private Equity Podcast. I am next year going to surge like the rest of the NASDAQ this year. It's not that year. Thank you for listening.
Episode: Amazon, Apple, & My Physical Fitness – 10-25-25
Date: October 25, 2025
In this concise solo episode, Scott Becker draws a playful and insightful parallel between the performance of tech giants Amazon and Apple in the financial markets and his own year in physical fitness. Becker candidly shares personal reflections while also addressing broader trends among both stocks and health and wellness, particularly referencing the impact of GLP-1 drugs (like Ozempic and Wegovy) on fitness trends.
The “Magnificent Seven” technology stocks (a group including Microsoft, Google, Meta, Tesla, Amazon, Apple, etc.) have seen a remarkable year overall in the NASDAQ.
Amazon is up ~2% and Apple is up ~5% year to date, which Becker characterizes as “okay,” but not extraordinary compared to their peers.
[00:20] Scott Becker: "The Magnificent Seven this year and the Nasdaq this year are overall having a terrific, terrific year. In contrast, Apple is up about 5% and Amazon's up about 2%."
Becker likens his own fitness journey to the stock performance of Apple and Amazon. While the broader “market” (his peers) is surging—often with the help of GLP-1 weight-loss drugs—his own results are modest by comparison.
His weight is up about 2%, mirroring Amazon’s 2% growth. He openly shares disappointment in not achieving his desired goals ("wanted it down about 2%").
[00:40] Scott Becker: "My weight's up about 2%. I really wanted it down about 2%. So that is the similarity to Amazon. We're both up about 2% this year."
Many individuals are seeing tremendous success in their fitness journeys, attributed in part to popular GLP-1 drugs (Ozempic, Wegovy, etc.), likening this trend to the other outperforming tech stocks like Google and Meta.
[01:10] Scott Becker: "So many people on these GLP1s, this Ozempic, the Novo Nordisk pill, or Shot, the Wegovy, and they seem to be all doing great. So their fitness is surging like the rest of the Magnificent Seven."
Becker draws a humorous but honest conclusion: while others (and other stocks) are surging, he, Apple, and Amazon are just “doing okay.”
Tesla: up 10-12%
Google: up 33%
Meta: up 25%
Microsoft: up 24%
Becker uses this to juxtapose his year and highlight high performers versus “steady” ones.
[01:30] Scott Becker: "Even Tesla's up 10–12% now. Google's up 33%. Meta Platforms is up 25%. Microsoft's up 24% or so."
Becker closes with optimism, intent on his own “surge” in the coming year.
[02:30] Scott Becker: "I am next year going to surge like the rest of the NASDAQ this year. It's not that year."
On personal progress:
"My weight's up about 2%. I really wanted it down about 2%. So that is the similarity to Amazon. We're both up about 2% this year."
(Scott Becker – 00:40)
On fitness trends:
"So many people on these GLP1s, this Ozempic, the Novo Nordisk pill, or Shot, the Wegovy, and they seem to be all doing great. So their fitness is surging like the rest of the Magnificent Seven."
(Scott Becker – 01:10)
Hopeful outlook:
"I am next year going to surge like the rest of the NASDAQ this year. It's not that year."
(Scott Becker – 02:30)
Scott Becker maintains a self-deprecating, direct, and lighthearted tone, infusing market analogies with personal anecdotes that make the parallel both informative and relatable.
This short episode is a blend of market intelligence and personal reflection, using the metaphor of stock performance to talk about both business trends and individual health journeys. Becker’s candor about not being a high-flyer this year—alongside Apple and Amazon—offers listeners both humor and perspective, while his acknowledgment of new fitness trends adds a timely business-health crossover. The message closes with optimism and resolve for the future.